In this webinar, Dr. Jamuar discusses the optimal technique for the detection of somatic mosaicism. He evaluates the limitations of Sanger sequencing and highlights the advantages of targeted next-generation sequencing (NGS), sharing findings from his paper, Somatic Mutations in Cerebral Cortical Malformations that was published in the New England Journal of Medicine. Webinar at a glance - Learn about somatic mutations and threshold of detection.  -Understand the prevalence of somatic mutations in neurodevelopmental disease. -Evaluate an optimal technique for somatic mosaicism detection -Limitations of Sanger sequencing -Advantages of targeted NGS Presenter: Dr. Saumya Jamuar Consultant, Genetics Service KK Women's and Children's Hospital, Singapore A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina product videos https://www.youtube.com/playlist?list=PLKRu7cmBQlaj6YuZmkfxZcT9twqDgP2Xd View Illumina support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM